Abbott's FreeStyle Libre 2 Receives National Reimbursement In France For All People With Diabetes Who Use Insulin
Portfolio Pulse from Happy Mohamed
Abbott's FreeStyle Libre 2 continuous glucose monitoring system has received national reimbursement in France for all people with diabetes who use insulin. France is the first European country to grant national reimbursement for people who use basal insulin, following similar expansions in Japan and the U.S. (Medicare).
June 22, 2023 | 1:01 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Abbott's FreeStyle Libre 2 receives national reimbursement in France, expanding access to continuous glucose monitoring for all insulin-using diabetics.
The national reimbursement in France for Abbott's FreeStyle Libre 2 will increase the number of people eligible to use the technology, potentially boosting sales and revenues for the company. This expansion follows similar reimbursement coverage in Japan and the U.S., indicating a growing global acceptance of the product.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100